Host Fred Goldstein invites Jennifer Mathieu, Senior Vice President, Professional & Government Affairs to discuss the Prescription Digital Therapeutics Act, the Medicaid MVPs for Patient Act and other AMCP legislative priorities.
On May 15, 2024, the Centers for Medicare and Medicaid Services (CMS)
released a statement regarding its May 2023 proposed rule titled Misclassification
of Drugs, Program Administration and Program Integrity Updates Under the
Medicaid Drug Rebate Program (Proposed Rule).
